Episode 1: Defining the business of Psychedelics - a podcast by Zeifmans LLP
from 2020-08-05T16:00
On our first ever episode of, Micro-dosing with Zeifmans, our host, Larry Zeifman is joined by this week's guests, James Lanthier, CEO of Mindset Pharma Inc. and Henri-Sant Cassia, Founding-Partner of the Conscious Found - together they will begin to define the business of the psychedelics industry.
Have questions or want to learn more? Contact us direct at info@zeifmans.ca.
Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.
Mindset Pharma is a drug discovery business focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders. Founded by serial entrepreneurs and domain experts in drug development and medicinal chemistry and based in Toronto, Canada, Mindset is assembling a proprietary library of transformative psychedelic intellectual property designed to address chronic neuropsychiatric disorders efficiently and safely.
The Conscious Fund invests in early stage ventures in plant based medicine.
Further episodes of Micro-dosing with Zeifmans: Short podcasts on demystifying the business of psychedelics
Further podcasts by Zeifmans LLP
Website of Zeifmans LLP